Larimar Therapeutics (LRMR) Long-Term Debt Repayments: 2015-2020
Historic Long-Term Debt Repayments for Larimar Therapeutics (LRMR) over the last 2 years, with Mar 2020 value amounting to $1.8 million.
- Larimar Therapeutics' Long-Term Debt Repayments was N/A to $1.8 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2019, which is N/A change from last year.
- Per Larimar Therapeutics' latest filing, its Long-Term Debt Repayments stood at $1.8 million for Q1 2020, which was down 0.05% from $1.8 million recorded in Q4 2019.
- Larimar Therapeutics' 5-year Long-Term Debt Repayments high stood at $1.8 million for Q4 2019, and its period low was $712,000 during Q1 2016.
- Over the past 2 years, Larimar Therapeutics' median Long-Term Debt Repayments value was $1.8 million (recorded in 2020), while the average stood at $1.8 million.
- Data for Larimar Therapeutics' Long-Term Debt Repayments shows a peak YoY soared of 67.99% (in 2017) over the last 5 years.
- Quarterly analysis of 4 years shows Larimar Therapeutics' Long-Term Debt Repayments stood at $756,000 in 2016, then spiked by 67.99% to $1.3 million in 2017, then reached $1.8 million in 2019, then reached $1.8 million in 2020.
- Its Long-Term Debt Repayments stands at $1.8 million for Q1 2020, versus $1.8 million for Q4 2019 and $1.8 million for Q3 2019.